Norway Savings Bank’s iShares Biotechnology ETF IBB Stock Holding History

Norway Savings Bank’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-15	Closed	-$2K	–	320
2021 Q1	$2K	Hold	15	–	–	﹤0.01%	301
2020 Q4	$2K	Hold	15	–	–	﹤0.01%	381
2020 Q3	$2K	Hold	15	–	–	﹤0.01%	286
2020 Q2	$2K	Hold	15	–	–	﹤0.01%	248
2020 Q1	$2K	Sell	15 -15	-50%	-$1.73K	﹤0.01%	251
2019 Q4	$4K	Sell	30 -60	-67%	-$6.69K	﹤0.01%	244
2019 Q3	$9K	Sell	90 -6	-6%	-$628	0.01%	217
2019 Q2	$10K	Hold	96	–	–	0.01%	212
2019 Q1	$11K	Sell	96 -105	-52%	-$11.5K	0.01%	206
2018 Q4	$19K	Sell	201 -6	-3%	-$637	0.02%	195
2018 Q3	$25K	Sell	207 -243	-54%	-$28.6K	0.02%	191
2018 Q2	$49K	Sell	450 -222	-33%	-$23.7K	0.04%	161
2018 Q1	$72K	Sell	672 -499	-43%	-$55.3K	0.07%	147
2017 Q4	$125K	Sell	1,171 -2,267	-66%	-$242K	0.12%	113
2017 Q3	$382K	Sell	3,438 -3,357	-49%	-$359K	0.37%	65
2017 Q2	$703K	Sell	6,795 -1,077	-14%	-$106K	0.69%	45
2017 Q1	$769K	Sell	7,872 -2,577	-25%	-$247K	0.79%	42
2016 Q4	$924K	Buy	+10,449	New	+$951K	0.86%	39

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Norway Savings Bank's IBB Position: Q2 2021 in Review

Norway Savings Bank sold out of iShares Biotechnology ETF (IBB) in Q2 2021, closing a stake of 15 shares — an estimated $2K sold.

Norway Savings Bank first reported a position in IBB in Q4 2016 and held it in 18 quarters. The position peaked at $924K in Q4 2016. 863 funds tracked by Wall St. Rank hold IBB as of Q2 2021.

Norway Savings Bank reported no remaining iShares Biotechnology ETF position as of Q2 2021 after selling out during the quarter.
Norway Savings Bank sold 15 iShares Biotechnology ETF shares in Q2 2021, an estimated $2K.
Norway Savings Bank first reported a position in iShares Biotechnology ETF in Q4 2016 and held it in 18 quarters.
Norway Savings Bank's iShares Biotechnology ETF position peaked at $924K in Q4 2016.
863 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2021.

Based on Norway Savings Bank's 13F filing for Q2 2021, filed 15 Jul 2021.